Authors
Latest:
Current approaches to treatment of uveitis with autoimmune diseaseUnderlying autoimmune disease alters uveitis therapy.
Latest:
Personalising glaucoma surgery: The role of MIGSMinimally invasive glaucoma surgery (MIGS) is appealing to glaucoma patients and surgeons; however, it should not be adopted without further high-quality research and careful reporting. Selection of the appropriate treatment for individual patients must be evidence based.
Latest:
Retinal imaging to detect Alzheimer disease: machine learning modelAn interdisciplinary team at Duke University has developed a proof-of-concept machine learning model capable of detecting symptomatic Alzheimer disease using multimodal retinal imaging data.
Latest:
Brolucizumab for neovascular AMD: Safety guidance and clinician perspectivesAlthough the majority of patients experience benefit with brolucizumab for the treatment of nAMD without severe adverse events, the risk of retinal vasculitis and/or retinal vascular occlusion needs to be balanced with potential benefits.
Latest:
Using swept-source OCT and OCT angiography to image choroidal tumoursSS-OCT provides a clear view of the eye’s internal structures and any abnormalities, helping to differentiate benign from malignant lesions.
Latest:
AAO 2023: Suprachoroidal outflow enhancement without implantable hardware: surgical technique and clinical results of a novel supraciliary MIGSInvestigators found that ab-interno implantation of a supraciliary allograft bio-tissue successfully reduced intraocular pressure with comparable safety to other minimally invasive glaucoma surgical procedures
Latest:
Stating the facts about combination myopia management treatmentsGrowing evidence supports dual therapy to slow progression.
Latest:
Assessing barriers to retinal care during a pandemicA global survey of retinal experts assessed their perceptions of evolving clinical practice in the Covid-19 era, focusing on digital teleophthalmology, home monitoring and decentralised patient care.
Latest:
Simplifying glaucoma medical therapy for patients in the United StatesCompounded medications are playing a central role in the process.
Latest:
Extended depth-of-focus IOLs: A reviewA look at how EDOF technology can be categorised into five types
Latest:
Orbis brings school-based eye health intervention to children in IndiaThe nonprofit's Refractive Error Among Children programme allows for early detection, prevention and appropriate management of visual impairment.
Latest:
Letter to the Editor: Intravitreal injections. Who should perform them?In response to a previously published article, three ophthalmologists present their views on intravitreal pharmacotherapy injections.
Latest:
Half a century of developments in ophthalmology: One doctor’s reflectionsDr Goes reflects on a life at the forefront of ophthalmology, considering advancements in technology and the knowledge that has changed his practice and improved outcomes for patients.
Latest:
US FDA approves RYZUMVI (Phentolamine Ophthalmic Solution) for the treatment of pharmacologically-induced mydriasisOcuphire Pharma and Viatris developed the drug together for the reversal of pharmacologically-induced mydriasis (RM) produced by adrenergic agonist or parasympatholytic agents
Latest:
Smartphone direct ophthalmoscope tech helps visualise optic discA smartphone direct ophthalmoscope attachment makes it possible to examine the optic nerve and distinguish whether its state of health is normal or abnormal.
Latest:
Insights into neovascular glaucoma: Pathogenesis and detection of diabetic retinopathyManagement of neovascular glaucoma focuses on decreasing retinal ischemia through panretinal photocoagulation and the injection of anti-VEGF agents
Latest:
The ins and outs of gene therapy for inherited optic neuropathiesA look at what’s in the therapeutic delivery pipeline for these disorders.
Latest:
An alternative approach to spectacle independenceLaser blended vision is a proven modality for presbyopia treatment, but its principles can be reproduced with EDOF IOLs
Latest:
Cosmetic surgery of the cornea: A new type of surgeryA colourful look at how the keratopigmentation technique offers therapeutic and cosmetic applications.
Latest:
Book excerpt: Rescuing failed penetrating keratoplasty graftsPenetrating keratoplasty remains a popular choice for certain patients
Latest:
Not just for eating: Grapes and potatoes help surgery trainees hone skillsThe pandemic has impacted ophthalmic surgical training. Exercises have been developed to provide key skills that can be practised simply at home and require no special equipment.
Latest:
New shape for an old device: A punctal plug that better fits into the punctumLarger 0.6-mm temporary plug features a tapered edge
Latest:
Rethinking dry eye disease with acute steroid treatmentLoteprednol etabonate suspension 0.25% demonstrates anti-inflammatory action and produces significant improvement in conjunctival hyperaemia and ocular discomfort.
Latest:
Not just for eating: Grapes and potatoes help surgery trainees hone skillsThe pandemic has impacted ophthalmic surgical training. Exercises have been developed to provide key skills that can be practised simply at home and require no special equipment.
Latest:
Extended dosing with faricimab = greater fluid control compared with aflibercept for DMEFaricimab could lower treatment burden for patients compared to aflibercept
Latest:
Amblyopia screening with the dynamic random dot stereotestA new amblyopia screening system that can be used on Android devices has performed better than some of the ‘gold standard’ stereotests in recent Hungarian studies.
Latest:
Focusing on laser trabeculoplasty, the glaucoma workhorseDebate continues over the best way to apply treatment option
Latest:
Electronic health records: how the pandemic highlighted the future of practice managementElectronic health records may be the future of practice management.
Latest:
Impact of Disease Activity Criteria on Dosing Interval Assignment in Clinical Trials in nAMDDr Marco Zarbin presents his talk from the 2023 ASRS annual meeting, where he explores the impact of disease activity criteria on drug durability estimations in clinical trials and includes a comparative analysis across multiple clinical trials in neovascular AMD (age-related macular degeneration).
